A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

PHASE3CompletedINTERVENTIONAL

Enrollment

1,125

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

Hypertension

Interventions

DRUG

aliskiren

Trial Locations (2)

Investigative Centers

Novartis Pharmaceuticals, Basel